Orphanet Journal of Rare Diseases
Scope & Guideline
Elevating awareness, enhancing lives.
Introduction
Aims and Scopes
- Clinical Research on Rare Diseases:
This includes studies that explore clinical presentations, treatment efficacy, and long-term outcomes of various rare diseases, contributing to improved management and care protocols. - Genetic Characterization and Genomics:
The journal emphasizes studies that delve into the genetic underpinnings of rare diseases, including mutation analysis, genotype-phenotype correlations, and the use of next-generation sequencing to enhance diagnostic accuracy. - Patient-Centered Outcomes and Quality of Life:
Research focusing on patient-reported outcomes, quality of life assessments, and the psychosocial impact of rare diseases on patients and their families is a core area, highlighting the importance of patient perspectives in treatment planning. - Health Economics and Burden of Illness:
The journal publishes studies that assess the economic impact of rare diseases, including cost-of-illness analyses and healthcare utilization, providing insights into the broader implications of these conditions on healthcare systems. - Innovative Therapeutics and Treatment Approaches:
Research on novel therapeutic interventions, including pharmacological treatments, gene therapies, and clinical trial methodologies to evaluate the effectiveness of new therapies for rare diseases. - Multidisciplinary and Collaborative Approaches:
The journal promotes interdisciplinary research that involves collaboration among clinicians, researchers, and patients, fostering a holistic approach to the study and management of rare diseases.
Trending and Emerging
- Telemedicine and Remote Care:
The COVID-19 pandemic has accelerated interest in telehealth solutions for managing rare diseases, leading to an increase in studies examining the effectiveness of remote consultations and digital health technologies. - Patient Engagement and Advocacy:
There is a growing focus on the role of patient advocacy groups and their influence on research priorities and treatment development, highlighting the importance of patient voices in shaping healthcare policies. - Longitudinal and Natural History Studies:
Research tracking the long-term progression of rare diseases is gaining traction, aiming to improve understanding of disease trajectories and inform future therapeutic strategies. - Integration of Artificial Intelligence in Rare Disease Research:
The application of AI and machine learning in analyzing large datasets for rare diseases is emerging, with studies exploring how these technologies can enhance diagnostics and treatment personalization. - Health Disparities in Rare Diseases:
An increasing emphasis on understanding the disparities in access to care and treatment outcomes among different populations affected by rare diseases is becoming more prevalent.
Declining or Waning
- Epidemiological Studies of Rare Diseases:
There has been a noticeable decline in publications solely focused on the epidemiology of rare diseases, possibly due to the increasing integration of epidemiological data into broader studies that also consider genetic and clinical aspects. - Traditional Case Reports:
The frequency of traditional case reports has diminished as the journal increasingly emphasizes systematic reviews and larger cohort studies that provide more comprehensive data. - Single-Country Focused Studies:
Research that concentrates on rare diseases within a specific country is becoming less common, as there is a growing trend toward multi-national studies that provide a more global perspective on rare diseases.
Similar Journals
Journal of Istanbul Faculty of Medicine-Istanbul Tip Fakultesi Dergisi
Connecting diverse disciplines for a healthier tomorrow.The Journal of Istanbul Faculty of Medicine (Istanbul Tip Fakultesi Dergisi), published by ISTANBUL UNIVERSITY, FACULTY OF MEDICINE, is an esteemed open-access journal that has been committed to disseminating significant medical research since becoming open access in 2017. As a platform for transformative scholarly work, this journal is situated in Turkey and actively engages with diverse medical disciplines to contribute to the collective understanding of health and medicine. Featuring a range of studies that span various facets of medical science, the journal is categorized within the Q4 quartile in Medicine (miscellaneous) for 2023, with its Scopus rankings placing it at #586 out of 636 in the General Medicine category, marking it as a resource that is gaining traction within the academic community. This journal aims to serve as a vital resource for researchers, healthcare professionals, and students alike, fostering the exchange of ideas and innovation in medicine. By providing public access to its content, it underscores the importance of open science in enhancing knowledge sharing and collaboration across borders. For those interested in advancing their research and professional development, the Journal of Istanbul Faculty of Medicine is an invaluable tool for staying informed on the latest findings and discussions in the medical field.
Reumatologia Clinica
Transforming knowledge into practice in rheumatic health.Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.
Expert Opinion on Orphan Drugs
Connecting science and policy for orphan drug advancements.Expert Opinion on Orphan Drugs is a pivotal academic journal published by Taylor & Francis Ltd, focusing on the burgeoning field of orphan drugs, which are often essential for treating rare diseases. As an integral source of insights and advancements from 2013 to 2024, this journal aims to bridge the gap between emerging scientific research and clinical application, providing a platform for authors to discuss pharmacological innovations and policy implications. With its ISSN 2167-8707, the journal has established a reputably rigorous editorial process and is indexed in Scopus, showcasing its relevance with ranks in various pharmacology and health policy disciplines. Though currently not an open-access journal, it endeavors to deliver high-quality articles that are vital for researchers, healthcare professionals, and policy makers aiming to navigate the complexities and challenges in the orphan drug landscape. It is categorized in Q4 for Health Policy and Q3 for Pharmacology in recent evaluations, reflecting its accessible yet scholarly contributions to this niche area of medical research.
Clinical Medicine & Research
Connecting clinical practice with cutting-edge research.Clinical Medicine & Research is a premier peer-reviewed journal published by Marshfield Clinic, dedicated to advancing the field of medical science with a focus on clinical and community-based care. Established in 2003, the journal showcases groundbreaking research and innovative practices aimed at improving patient outcomes and optimizing healthcare delivery. With an ISSN of 1539-4182 and an E-ISSN of 1554-6179, it has garnered recognition in the academic community, achieving a Q2 ranking in Community and Home Care and a Q3 ranking in Miscellaneous Medicine categories as of 2023. The journal’s Scopus rankings further emphasize its relevance, placing it at #263 in General Medicine and #20 in Community and Home Care. Although it operates under a subscription model, Clinical Medicine & Research remains pivotal for researchers, professionals, and students seeking to stay informed about the latest advancements in clinical practice and healthcare methodologies, with an eye toward its impact on the broader medical landscape through 2024 and beyond.
Pulmonary Circulation
Championing open access to vital pulmonary research.Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.
Boletin de Pediatria
Innovating Child Health: Where Research Meets PracticeBoletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.
European Journal of Medical Genetics
Innovating the Future of Medical GeneticsEuropean Journal of Medical Genetics, published by Elsevier, is a pivotal platform dedicated to advancing knowledge in the fields of medical genetics and its clinical applications. With an ISSN of 1769-7212 and an E-ISSN of 1878-0849, this journal fosters innovative research and insights into the genetic factors that influence human health. Ranked in the Q3 category for both Genetics and Clinical Genetics, and achieving notable recognition in Medicine (miscellaneous) with a Q2 positioning, it strives to bridge the gap between laboratory findings and clinical practice. Operating in an Open Access format, the journal aims at maximally disseminating essential findings to researchers, professionals, and students alike, ensuring that critical advances in genetics are accessible to the global medical community. With converged publication years spanning from 2005 to 2024, the journal strengthens its mission to be at the forefront of genetic research that informs clinical methodologies and fosters improved healthcare outcomes.
Molecular Genetics & Genomic Medicine
Exploring innovations in genetics and healthcare.Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.
ACTA CLINICA BELGICA
Pioneering insights in general medicine since 1946.ACTA CLINICA BELGICA is a distinguished peer-reviewed journal published by Taylor & Francis Ltd that has been a vital contributor to the field of general medicine since its inception in 1946. With an ISSN of 1784-3286 and an E-ISSN of 2295-3337, it serves as an essential platform for disseminating novel research and clinical advancements. The journal is currently ranked in the 3rd quartile (Q3) of the Medicine (miscellaneous) category, placing it at an impressive 76th percentile among its peers in the Scopus database, which reflects its importance in the medical community. Although it does not offer Open Access options, ACTA CLINICA BELGICA provides a comprehensive overview of contemporary research, clinical practices, and medical innovations, making it a crucial resource for researchers, healthcare professionals, and students committed to enhancing their knowledge and practices.
Indian Journal of Rheumatology
Championing research that transforms rheumatologic practices.Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.